Transdermal drug delivery may be defined, in its broadest sense, as the administration of?medicines to the skin?which will deliver the active ingredient into the systemic circulation at therapeutic levels.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Passive Transdermal Drug Delivery industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Microfluidics
Smart Pill Technology (SPT)
Market Segment by Product Application
Clinic
Hospital
Others
Finally, the report provides detailed profile and data information analysis of leading company.
3M
Actavis, Inc.
Bayer AG
Boehringer Ingelheim GmbH
Corium International, Inc.
Echo Therapeutics, Inc.
GlaxoSmithKline plc
Johnson & Johnson (Janssen Pharmaceuticals Inc.)
Mylan N.V.
Novartis AG
Noven Pharmaceuticals, Inc.
Transdermal Corp.
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Passive Transdermal Drug Delivery consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Passive Transdermal Drug Delivery market by identifying its various subsegments.
3.Focuses on the key global Passive Transdermal Drug Delivery manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Passive Transdermal Drug Delivery with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Passive Transdermal Drug Delivery submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Passive Transdermal Drug Delivery Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Passive Transdermal Drug Delivery Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Passive Transdermal Drug Delivery Segment by Type
2.1.1 Microfluidics
2.1.2 Smart Pill Technology (SPT)
2.2 Market Analysis by Application
2.2.1 Clinic
2.2.2 Hospital
2.2.3 Others
2.3 Global Passive Transdermal Drug Delivery Market Comparison by Regions (2017-2027)
2.3.1 Global Passive Transdermal Drug Delivery Market Size (2017-2027)
2.3.2 North America Passive Transdermal Drug Delivery Status and Prospect (2017-2027)
2.3.3 Europe Passive Transdermal Drug Delivery Status and Prospect (2017-2027)
2.3.4 China Passive Transdermal Drug Delivery Status and Prospect (2017-2027)
2.3.5 Japan Passive Transdermal Drug Delivery Status and Prospect (2017-2027)
2.3.6 Southeast Asia Passive Transdermal Drug Delivery Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Passive Transdermal Drug Delivery Industry Impact
2.5.1 Passive Transdermal Drug Delivery Business Impact Assessment - Covid-19
2.5.2 Market Trends and Passive Transdermal Drug Delivery Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Passive Transdermal Drug Delivery Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Passive Transdermal Drug Delivery Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Passive Transdermal Drug Delivery Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Passive Transdermal Drug Delivery Manufacturer Market Share
3.5 Top 10 Passive Transdermal Drug Delivery Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Passive Transdermal Drug Delivery Market
3.7 Key Manufacturers Passive Transdermal Drug Delivery Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Passive Transdermal Drug Delivery Industry Key Manufacturers
4.1 3M
4.1.1 Compan Detail
4.1.2 3M Passive Transdermal Drug Delivery Product Introduction, Application and Specification
4.1.3 3M 159 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 3M News
4.2 Actavis, Inc.
4.2.1 Compan Detail
4.2.2 Actavis, Inc. Passive Transdermal Drug Delivery Product Introduction, Application and Specification
4.2.3 Actavis, Inc. Passive Transdermal Drug Delivery Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 3M News
4.3 Bayer AG
4.3.1 Compan Detail
4.3.2 Bayer AG Passive Transdermal Drug Delivery Product Introduction, Application and Specification
4.3.3 Bayer AG Passive Transdermal Drug Delivery Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Bayer AG News
4.4 Boehringer Ingelheim GmbH
4.4.1 Compan Detail
4.4.2 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Product Introduction, Application and Specification
4.4.3 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Boehringer Ingelheim GmbH News
4.5 Corium International, Inc.
4.5.1 Compan Detail
4.5.2 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Product Introduction, Application and Specification
4.5.3 Corium International, Inc. Passive Transdermal Drug Delivery Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Corium International, Inc. News
4.6 Echo Therapeutics, Inc.
4.6.1 Compan Detail
4.6.2 Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Product Introduction, Application and Specification
4.6.3 Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Echo Therapeutics, Inc. News
4.7 GlaxoSmithKline plc
4.7.1 Compan Detail
4.7.2 GlaxoSmithKline plc Passive Transdermal Drug Delivery Product Introduction, Application and Specification
4.7.3 GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Johnson & Johnson (Janssen Pharmaceuticals Inc.)
4.8.1 Compan Detail
4.8.2 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Product Introduction, Application and Specification
4.8.3 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Johnson & Johnson (Janssen Pharmaceuticals Inc.) News
4.9 Mylan N.V.
4.9.1 Compan Detail
4.9.2 Mylan N.V. Passive Transdermal Drug Delivery Product Introduction, Application and Specification
4.9.3 Mylan N.V. Passive Transdermal Drug Delivery Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Mylan N.V. News
4.10 Novartis AG
4.10.1 Compan Detail
4.10.2 Novartis AG Passive Transdermal Drug Delivery Product Introduction, Application and Specification
4.10.3 Novartis AG Passive Transdermal Drug Delivery Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Novartis AG News
4.11 Noven Pharmaceuticals, Inc.
4.11.1 Compan Detail
4.11.2 Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Product Introduction, Application and Specification
4.11.3 Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 Noven Pharmaceuticals, Inc. News
4.12 Transdermal Corp.
4.12.1 Compan Detail
4.12.2 Transdermal Corp. Passive Transdermal Drug Delivery Product Introduction, Application and Specification
4.12.3 Transdermal Corp. Passive Transdermal Drug Delivery Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.12.4 Main Business Overview
4.12.5 Transdermal Corp. News
5 Global Passive Transdermal Drug Delivery Market Segment by Big Type
5.1 Global Passive Transdermal Drug Delivery Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Passive Transdermal Drug Delivery Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Passive Transdermal Drug Delivery Revenue and Market Share by Big Type (2017-2022)
5.2 Microfluidics Sales Growth Rate and Price
5.2.1 Global Microfluidics Sales Growth Rate (2017-2022)
5.2.2 Global Microfluidics Price (2017-2022)
5.3 Smart Pill Technology (SPT) Sales Growth Rate and Price
5.3.1 Global Smart Pill Technology (SPT) Sales Growth Rate (2017-2022)
5.3.2 Global Smart Pill Technology (SPT) Price (2017-2022)
6 Global Passive Transdermal Drug Delivery Market Segment by Big Application
6.1 Global Passive Transdermal Drug Delivery Sales Market Share by Big Application (2017-2022)
6.2 Clinic Sales Growth Rate (2017-2022)
6.3 Hospital Sales Growth Rate (2017-2022)
6.4 Others Sales Growth Rate (2017-2022)
7 Global Passive Transdermal Drug Delivery Forecast
7.1 Global Passive Transdermal Drug Delivery Revenue, Sales and Growth Rate (2022-2027)
7.2 Passive Transdermal Drug Delivery Market Forecast by Regions (2022-2027)
7.2.1 North America Passive Transdermal Drug Delivery Market Forecast (2022-2027)
7.2.2 Europe Passive Transdermal Drug Delivery Market Forecast (2022-2027)
7.2.3 China Passive Transdermal Drug Delivery Market Forecast (2022-2027)
7.2.4 Japan Passive Transdermal Drug Delivery Market Forecast (2022-2027)
7.2.5 Southeast Asia Passive Transdermal Drug Delivery Market Forecast (2022-2027)
7.2.6 Other Regions Passive Transdermal Drug Delivery Market Forecast (2022-2027)
7.3 Passive Transdermal Drug Delivery Market Forecast by Type (2022-2027)
7.3.1 Global Passive Transdermal Drug Delivery Sales Forecast by Type (2022-2027)
7.3.2 Global Passive Transdermal Drug Delivery Market Share Forecast by Type (2022-2027)
7.4 Passive Transdermal Drug Delivery Market Forecast by Application (2022-2027)
7.4.1 Global Passive Transdermal Drug Delivery Sales Forecast by Application (2022-2027)
7.4.2 Global Passive Transdermal Drug Delivery Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Passive Transdermal Drug Delivery Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Passive Transdermal Drug Delivery Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Passive Transdermal Drug Delivery
Figure Market Concentration Ratio and Market Maturity Analysis of Passive Transdermal Drug Delivery
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Passive Transdermal Drug Delivery Market Size by Big Type
Figure Global Market Share of Passive Transdermal Drug Delivery by Big Type in 2021
Figure Microfluidics Picture (2017-2022)
Global Passive Transdermal Drug Delivery Market Size by Big Application
Table Global Passive Transdermal Drug Delivery Market Size by Application
Figure Global Passive Transdermal Drug Delivery Market Share by Big Application in 2021
Figure Clinic Picture
Figure Hospital Picture
Figure Others Picture
Table Global Passive Transdermal Drug Delivery Comparison by Regions (M USD) (2017-2027)
Figure Global Passive Transdermal Drug Delivery Market Size (Million US$) (2017-2027)
Figure North America Passive Transdermal Drug Delivery Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Passive Transdermal Drug Delivery Revenue (Million US$) Growth Rate (2017-2027)
Figure China Passive Transdermal Drug Delivery Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Passive Transdermal Drug Delivery Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Passive Transdermal Drug Delivery Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Passive Transdermal Drug Delivery Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Passive Transdermal Drug Delivery Sales by Manufacturer (2017-2022)
Figure Global Passive Transdermal Drug Delivery Sales Market Share by Manufacturer in 2021
Table Global Passive Transdermal Drug Delivery Revenue by Manufacturer (2017-2022)
Figure Global Passive Transdermal Drug Delivery Revenue Market Share by Manufacturer in 2021
Table Global Passive Transdermal Drug Delivery Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Passive Transdermal Drug Delivery Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Passive Transdermal Drug Delivery Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Passive Transdermal Drug Delivery Market
Table Key Manufacturers Passive Transdermal Drug Delivery Product Type
Table Mergers & Acquisitions Planning
Table 3M Company Profile
Table Passive Transdermal Drug Delivery Product Introduction, Application and Specification of 3M
Table Passive Transdermal Drug Delivery Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Actavis, Inc. Company Profile
Table Passive Transdermal Drug Delivery Product Introduction, Application and Specification of Actavis, Inc.
Table Passive Transdermal Drug Delivery Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Actavis, Inc. Recent Development
Table Bayer AG Company Profile
Table Passive Transdermal Drug Delivery Product Introduction, Application and Specification of Bayer AG
Table Passive Transdermal Drug Delivery Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Bayer AG Main Business
Table Bayer AG Recent Development
Table Boehringer Ingelheim GmbH Company Profile
Table Passive Transdermal Drug Delivery Product Introduction, Application and Specification of Boehringer Ingelheim GmbH
Table Passive Transdermal Drug Delivery Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Boehringer Ingelheim GmbH Main Business
Table Boehringer Ingelheim GmbH Recent Development
Table Boehringer Ingelheim GmbH Main Business
Table Boehringer Ingelheim GmbH Recent Development
Table Corium International, Inc. Company Profile
Table Passive Transdermal Drug Delivery Product Introduction, Application and Specification of Corium International, Inc.
Table Passive Transdermal Drug Delivery Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Corium International, Inc. Main Business
Table Corium International, Inc. Recent Development
Table Echo Therapeutics, Inc. Company Profile
Table Passive Transdermal Drug Delivery Product Introduction, Application and Specification of Echo Therapeutics, Inc.
Table Passive Transdermal Drug Delivery Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Echo Therapeutics, Inc. Main Business
Table Echo Therapeutics, Inc. Recent Development
Table GlaxoSmithKline plc Company Profile
Table Passive Transdermal Drug Delivery Product Introduction, Application and Specification of GlaxoSmithKline plc
Table Passive Transdermal Drug Delivery Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table GlaxoSmithKline plc Main Business
Table GlaxoSmithKline plc Recent Development
Table Johnson & Johnson (Janssen Pharmaceuticals Inc.) Company Profile
Table Passive Transdermal Drug Delivery Product Introduction, Application and Specification of Johnson & Johnson (Janssen Pharmaceuticals Inc.)
Table Passive Transdermal Drug Delivery Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Johnson & Johnson (Janssen Pharmaceuticals Inc.) Main Business
Table Johnson & Johnson (Janssen Pharmaceuticals Inc.) Recent Development
Table Mylan N.V. Company Profile
Table Passive Transdermal Drug Delivery Product Introduction, Application and Specification of Mylan N.V.
Table Passive Transdermal Drug Delivery Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Mylan N.V. Main Business
Table Mylan N.V. Recent Development
Table Novartis AG Company Profile
Table Passive Transdermal Drug Delivery Product Introduction, Application and Specification of Novartis AG
Table Passive Transdermal Drug Delivery Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Novartis AG Main Business
Table Novartis AG Recent Development
Table Noven Pharmaceuticals, Inc. Company Profile
Table Passive Transdermal Drug Delivery Product Introduction, Application and Specification of Noven Pharmaceuticals, Inc.
Table Passive Transdermal Drug Delivery Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Noven Pharmaceuticals, Inc. Main Business
Table Noven Pharmaceuticals, Inc. Recent Development
Table Transdermal Corp. Company Profile
Table Passive Transdermal Drug Delivery Product Introduction, Application and Specification of Transdermal Corp.
Table Passive Transdermal Drug Delivery Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Transdermal Corp. Main Business
Table Transdermal Corp. Recent Development
Figure Global Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
Figure Global Passive Transdermal Drug Delivery Revenue and Growth Rate (2017-2022)
Table Global Passive Transdermal Drug Delivery Sales by Regions (2017-2022)
Figure Global Passive Transdermal Drug Delivery Sales Market Share by Regions in 2021
Table Global Passive Transdermal Drug Delivery Revenue by Regions (2017-2022)
Figure Global Passive Transdermal Drug Delivery Revenue Market Share by Regions in 2021
Figure North America Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
Figure Europe Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
Figure China Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
Figure Japan Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
Figure Southeast Asia Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
Figure Other Regions Passive Transdermal Drug Delivery Sales and Growth Rate (2017-2022)
Table Global Passive Transdermal Drug Delivery Sales by Big Type (2017-2022)
Table Global Passive Transdermal Drug Delivery Sales Market Share by Big Type (2017-2022)
Figure Global Passive Transdermal Drug Delivery Sales Market Share by Big Type in 2019
Table Global Passive Transdermal Drug Delivery Revenue by Big Type (2017-2022)
Table Global Passive Transdermal Drug Delivery Revenue Market Share by Big Type (2017-2022)
Table Global Passive Transdermal Drug Delivery Revenue Market Share by Big Type in 2019
Figure Global Microfluidics Sales Growth Rate (2017-2022)
Figure Global Microfluidics Price (2017-2022)
Figure Global Smart Pill Technology (SPT) Sales Growth Rate (2017-2022)
Table Global Passive Transdermal Drug Delivery Sales by Big Application (2017-2022)
Table Global Passive Transdermal Drug Delivery Sales Market Share by Big Application (2017-2022)
Figure Global Passive Transdermal Drug Delivery Sales Market Share by Big Application in 2019
Figure Global Clinic Sales Growth Rate (2017-2022)
Figure Global Hospital Sales Growth Rate (2017-2022)
Figure Global Others Sales Growth Rate (2017-2022)
Figure Global Passive Transdermal Drug Delivery Sales and Growth Rate (2022-2027)
Figure Global Passive Transdermal Drug Delivery Revenue and Growth Rate (2022-2027)
Table Global Passive Transdermal Drug Delivery Sales Forecast by Regions (2022-2027)
Table Global Passive Transdermal Drug Delivery Market Share Forecast by Regions (2022-2027)
Figure North America Sales Passive Transdermal Drug Delivery Market Forecast (2022-2027)
Figure Europe Sales Passive Transdermal Drug Delivery Market Forecast (2022-2027)
Figure China Sales Passive Transdermal Drug Delivery Market Forecast (2022-2027)
Figure Japan Sales Passive Transdermal Drug Delivery Market Forecast (2022-2027)
Figure Southeast Asia Sales Passive Transdermal Drug Delivery Market Forecast (2022-2027)
Figure Other Regions Sales Passive Transdermal Drug Delivery Market Forecast (2022-2027)
Table Global Passive Transdermal Drug Delivery Sales Forecast by Type (2022-2027)
Table Global Passive Transdermal Drug Delivery Market Share Forecast by Type (2022-2027)
Table Global Passive Transdermal Drug Delivery Sales Forecast by Application (2022-2027)
Table Global Passive Transdermal Drug Delivery Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Passive Transdermal Drug Delivery
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Passive Transdermal Drug Delivery Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Passive Transdermal Drug Delivery Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Passive Transdermal Drug Delivery Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Passive Transdermal Drug Delivery Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Passive Transdermal Drug Delivery Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Passive Transdermal Drug Delivery Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Passive Transdermal Drug Delivery Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Passive Transdermal Drug Delivery Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
3M
Actavis, Inc.
Bayer AG
Boehringer Ingelheim GmbH
Corium International, Inc.
Echo Therapeutics, Inc.
GlaxoSmithKline plc
Johnson & Johnson (Janssen Pharmaceuticals Inc.)
Mylan N.V.
Novartis AG
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)